Mobile
  • Search
  • Advanced search
  • Multi-criteria search
  • Who are we ?
  • Log in
  • Sign up
  • Français
  • English

Kusajili – Clinical trials directory

Your research

Clear all filters

Filtres
organs
Specialty
Type
Promoter
  • nct (1)
Country
  • Argentina (1)
  • Australia (1)
  • Austria (1)
  • Belgium (1)
  • Canada (1)
  • Chile (1)
  • China (1)
  • Czech Republic (1)
  • Estonia (1)
  • Finland (1)
  • France (1)
  • Germany (1)
  • Italy (1)
  • Korea, Republic of (1)
  • Mexico (1)
  • Morocco (1)
  • Netherlands (1)
  • Poland (1)
  • Russian Federation (1)
  • Sweden (1)
  • Tunisia (1)
  • Turkey (1)
  • United States (1)
Source
  • nct (1)
Phase
  • complete (1)

Country: Italy,Sweden,China,Russian Federation,Belgium,Germany,Australia,United States,France
nct Update Il y a 5 ans

Efficacy & Safety of Dronedarone Versus Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation The objective of this study is to compare the efficacy and safety of dronedarone to that of amiodarone for the treatment of patients with atrial fibrillation.

  • Country Argentina, Australia, Austria, Belgium, Canada, Chile, China, Czech Republic, Estonia, Finland, France, Germany, Italy, Korea, Republic of, Mexico, Morocco, Netherlands, Poland, Russian Federation, Sweden, Tunisia, Turkey, United States,
  • organs None
  • Specialty None
Closed trial
More information

  • 1

Who are we ?

Kusajili was created to respond to a request from physicians to simplify access to patient registries and inclusion. Kusajili is regularly updated according to new French and international trials. [email protected]

Kusajili and MyHomeDoctor

MyHomeDoctor software unique to the world, created with surgeons, for follow-up and analysis of patient follow-up. Kusajili and MyHomeDoctor partners, help clinical research through improved patient follow-up and automatic inclusion.

Sign up

Sign up
Français - English - CGU - Cookies

©2024 Kusajili France - Kusajili International - MedSynApps - MyHomeDoctor.